neurology Archives

Neuronal subtypes in genetic disorder

Sep. 6, 2012—Inhibitory neurons that connect and regulate signaling in the brain (interneurons) may contribute to epilepsy and autism in patients with tuberous sclerosis complex.

Targeting new pathways to ease pain

Aug. 30, 2012—The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.

Concussion testing for young athletes

Jul. 30, 2012—The Vanderbilt Sports Concussion Center is now offering pre-concussion baseline testing to all community recreational athletes, in advance of many high-impact seasonal sports resuming this fall.

Photo: END technologists

Jul. 26, 2012—From left, Amanda Worrell, Martha Sellers, Lauren Andal and Latina Woods celebrate their graduation from VUMC’s electroneurodiagnostic (END) technologist program. They are the first graduates of the 18-month allied health program, which trained them to record electroencephalograms (EEGs) and provided an introduction to other END technologies, including intraoperative neuromonitoring, nerve conduction studies, evoked potential studies,...

Vanderbilt-led team to develop ‘microbrain’ to improve drug testing

Jul. 24, 2012—Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process.

Roots of childhood brain tumors

Jun. 14, 2012—Cells in the back of the developing brain can give rise to brain tumors, suggesting they may be a target for treatment.

Vanderbilt honors top graduates during Commencement

May. 11, 2012—Top scholars from Vanderbilt University’s undergraduate and professional schools are being honored with Founder’s Medals during Commencement on Friday, May 11.

Probing epilepsy’s molecular sparks

May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

Minds wide open: Neuroscience at Vanderbilt

Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

Let there be light and melatonin

Nov. 4, 2011—Light and the hormone melatonin may play important roles in the developing brain.

Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.